You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Astex

Showing 1 - 25 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer Trial in Boston (Oral Decitabine, Durvalumab)

Active, not recruiting
  • Head and Neck Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 30, 2022

Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

Recruiting
  • MDS/MPN
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2022

Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer Trial in Sutton (ASTX660, Pembrolizumab)

Recruiting
  • Advanced Cancer
  • +2 more
  • Sutton, United Kingdom
    Royal Marden NHS Foundation Trust
May 25, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine and Cedazuridine, Venetoclax)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Solid Tumor Trial in Los Angeles, Baltimore (Decitabine, Cedazuridine)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +1 more
Nov 18, 2021

Malignant Peripheral Nerve Sheath Tumors (MPNST) Trial in United States (ASTX727)

Recruiting
  • Malignant Peripheral Nerve Sheath Tumors (MPNST)
  • Basking Ridge, New Jersey
  • +6 more
Aug 25, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Small Cell Lung Cancer, Extensive-stage Small Cell Lung Cancer Trial in United States (Guadecitabine, Carboplatin)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extensive-stage Small Cell Lung Cancer
  • Indianapolis, Indiana
  • +3 more
Feb 14, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 17, 2022

Metastatic Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Tumor Trial in Indianapolis, Winston-Salem

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Sep 28, 2021

Metastatic Colorectal Cancer Trial in Baltimore (CY, GVAX, SGI-110)

Completed
  • Metastatic Colorectal Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 26, 2021

MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

Recruiting
  • MDS
  • AML
  • Amiens, France
  • +15 more
Jul 21, 2022

Colorectal Adenocarcinoma, CpG Island Methylator Phenotype, Metastatic Microsatellite Stable Colorectal Carcinoma Trial in Los

Withdrawn
  • Colorectal Adenocarcinoma
  • +7 more
  • Los Angeles, California
  • +1 more
Apr 1, 2021

Neurological Cancer Trial in Boston (ASTX727)

Recruiting
  • Neurological Cancer
  • Boston, Massachusetts
  • +2 more
Sep 5, 2020

Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)

Terminated
  • Acute Myeloid Leukemia
  • Myeloid Dysplastic Syndrome
  • Buffalo, New York
  • +20 more
Jan 21, 2022

Previously Treated Metastatic Colorectal Cancer Trial in Netherlands, United States (SGI-110 Dose Escalation, Regorafenib,

Completed
Has Results
  • Previously Treated Metastatic Colorectal Cancer
  • SGI-110 Dose Escalation
  • +4 more
  • Los Angeles, California
  • +3 more
Sep 14, 2020

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

Non-Hodgkins Lymphoma, Solid Tumor Trial in Vancouver, Ottawa (Aurora kinase inhibitor AT9283)

Completed
  • Non-Hodgkins Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Aurora kinase inhibitor AT9283
  • Vancouver, British Columbia, Canada
  • +1 more
Apr 6, 2020

Chronic Lymphocytic Leukemia Trial in Winnipeg, Hamilton, Toronto (AT7519M)

Completed
  • Chronic Lymphocytic Leukemia
  • Winnipeg, Manitoba, Canada
  • +2 more
Apr 6, 2020

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Relapsed/Refractory Peripheral T-cell Lymphoma Trial in Fairport (Tolinapant, Decitabine + Cedazuridine)

Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Aurora, Colorado
  • +2 more
Jan 3, 2023

Multiple Myeloma Trial in Canada (AT9283)

Completed
  • Multiple Myeloma
  • Calgary, Alberta, Canada
  • +5 more
Apr 6, 2020

Acute Myeloid Leukemia Trial in United States (TAS1440, TAS1440 + ATRA)

Recruiting
  • Acute Myeloid Leukemia
  • Tucson, Arizona
  • +8 more
Jan 3, 2023